The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
HER-2 as a Predictive Marker in Node-Positive (N+) Breast Cancer (BC) Patients (Pts) Randomly Treated with CMF or an Anthracycline-Based Regimen.
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Simon Chowdhury
Honoraria - Astellas Medivation; Clovis Oncology; Johnson & Johnson; Sanofi
Consulting or Advisory Role - Astellas Medivation; Clovis Oncology; Johnson & Johnson; Sanofi
Speakers' Bureau - Astellas Medivation; Clovis Oncology; Johnson & Johnson; Sanofi
Research Funding - Clovis Oncology
Travel, Accommodations, Expenses - Astellas Medivation; Johnson & Johnson
 
Boris A. Hadaschik
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Janssen
Research Funding - Astellas Medivation; Bristol-Myers Squibb; Janssen; Profound Medical
Travel, Accommodations, Expenses - Janssen
 
Julie Nicole Graff
Honoraria - Astellas Medivation; Bayer; Janssen Oncology
Consulting or Advisory Role - Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Oncoresponse: Exceptional responders
Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Merck Sharp & Dohme
 
David Olmos
Consulting or Advisory Role - Astellas Medivation; Bayer; Genentech; Janssen; Sanofi
Research Funding - AstraZeneca; Bayer; Janssen
 
Paul N. Mainwaring
Honoraria - Janssen; Roche; Sanofi
Consulting or Advisory Role - Janssen; Roche; Sanofi
 
Hiroji Uemura
Honoraria - Astellas Medivation; Bayer; Janssen; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Takeda
Travel, Accommodations, Expenses - Bayer; Janssen; Takeda
 
Angela Lopez-Gitlitz
No Relationships to Disclose
 
Geralyn Carol Trudel
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Byron M. Espina
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Youyi Shu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Youn C. Park
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Wayne R. Rackoff
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson
 
Margaret K. Yu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Gilead Sciences; Janssen Oncology
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst)